Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific Corporation

http://www.bostonscientific.com

Latest From Boston Scientific Corporation

Finance Watch: Lilly, Fosun Reveal Strategic Investments In Start-Ups, Growth-Stage Firms

Private Company Edition: Lilly will open a third accelerator, this time in San Diego, and Fosun partnered with Treehill to help later-stage firms get over the finish line. Also, Flagship – after recent UK investments – signals its next fund will total $3bn. ArrivoBio and Alto Neuroscience raised $45m each.

Financing Innovation

Merck As Anchor, Scale As Lever, Aurobindo Looks To Spar With Lonza, WuXi Group

Starting off with MSD as an anchor partner, Aurobindo plans to eventually spar with the likes of WuXi and Lonza while building scale for its biologics CDMO business. Meanwhile, EMA approval for a greenfield project in China and an US FDA nod for Ryzneuta, licensed from Yifan’s Evive Biotech, signal a boost.

Strategy Sales & Earnings

Updated: J&J Will Pay At Least $400m For Laminar To Add Stroke-Stopping Technology

Currently available catheter-based devices for left-atrial appendage closure block the opening from the left atrium into the appendage, while Laminar’s innovative approach uses rotational motion to “eliminate” the LAA.

M & A Neurology

Olema Boosts Its Partnering Position With SERD Combo Data

Scrip caught up with Olema CEO Sean Bohen ahead of a crucial combination data readout due this month for its novel SERD, palazestrant, which it hopes will put the drug on the path to a $10bn-plus breast cancer market.

Clinical Trials Companies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Radiofrequency Devices
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Other Names / Subsidiaries
    • Apama Medical
    • Asthmatx
    • Atritech, Inc.
    • Augmenix, Inc.
    • Biocompatibles International plc
    • BridgePoint Medical, Inc.
    • BTG plc
    • BTG Specialty Pharmaceuticals
    • Cameron Health, Inc.
    • Cardiovascular Imaging Systems, Inc.
    • CellMed
    • Cosman Medical Inc.
    • CryoCor
    • Cryterion Medical, Inc.
    • Devoro Medical, Inc.
    • Ekos Corporation
    • EMcision, Ltd.
    • EndoTex Interventional Systems, Inc.
    • EndoChoice Holdings, Inc.
    • Enteric Medical Technologies, Inc.
    • Galil Medical, Inc.
    • Guidant Corporation
    • Intelect Medical, Inc.
    • IoGyn, Inc.
    • Labcoat Limited
    • Meadox Medicals, Inc.
    • Novate Medical Ltd.
    • nVision Medical Corporation
    • NxThera, Inc.
    • Pathworks Anatomic Pathology Laboratory
    • PneumRx Inc.
    • Precision Vascular Systems, Inc.
    • Protherics PLC
    • RadioTherapeutics Corporation
    • Revascular Therapeutics, Inc.
    • Roxwood Medical
    • Rubicon Medical Corporation
    • SCIMED, Inc.
    • Securus Medical Group, Inc.
    • Symetis SA
    • VENITI
    • Vessix Vascular, Inc.
    • Xlumena Inc.
UsernamePublicRestriction

Register